| Ms Nicole C Colline, APRN | |
|
1 Cellini Pl Ste 102, West Haven, CT 06516-1666 | |
| (203) 932-6481 | |
| (203) 932-4051 |
| Full Name | Ms Nicole C Colline |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1 Cellini Pl Ste 102, West Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083808273 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 3689 (Connecticut) | Secondary |
| 363L00000X | Nurse Practitioner | CERT # F0707246 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nicole C Colline, APRN 66 Nicole Dr, Milford, CT 06460-6969 Ph: (203) 377-5733 | Ms Nicole C Colline, APRN 1 Cellini Pl Ste 102, West Haven, CT 06516-1666 Ph: (203) 932-6481 |
News Archive
Just a day after New York passed a landmark gun control law which would require mental health workers to report to authorities patients deemed to be a danger to themselves or others, President Barack Obama is also expected to unveil his gun control agenda. The New York measure, however, is already drawing criticism from experts who worry that its reporting requirement could hinder treatment.
Placenta accreta spectrum (PAS) disorder is a life-threatening condition that occurs when the placenta remains attached to the uterus after childbirth.
Genentech, Inc., a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ACTEMRA (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).
Omthera Pharmaceuticals, a privately-held emerging specialty pharmaceuticals company, today announced data from its ECLIPSE trial, designed to evaluate the bioavailability of Epanova™, the Company's lead compound for the treatment of very high triglycerides, in comparison to Lovaza®, the leading prescription Omega 3.
› Verified 8 days ago
Ms. Michele V Coral, APRN,CS Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave # 116-a, West Haven, CT 06516 Phone: 203-932-5711 | |
Susan Marchitto, PNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6 Cove Brook Rd, West Haven, CT 06516 Phone: 203-641-0765 | |
Christine B Paranal, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 150 Arlington St, West Haven, CT 06516 Phone: 203-934-2691 | |
Olutoyin Adesola, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 687 Campbell Ave, West Haven, CT 06516 Phone: 203-932-6481 | |
Ms. Clarice Elizabeth Grens, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 | |
Tracie Nalley, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 687 Campbell Ave, West Haven, CT 06516 Phone: 203-932-6481 | |
Mrs. Sandra Ntreh, APRN, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 115 Ardale St, West Haven, CT 06516 Phone: 860-796-5683 |